Marc Dauer Selected Research

ISCOMs

7/2011	ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
2/2011	An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Dauer Research Topics

Disease

8	Neoplasms (Cancer) 04/2015 - 04/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015 - 07/2005
4	Colitis 09/2010 - 05/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2014 - 02/2004
3	Inflammation (Inflammations) 09/2010 - 09/2003
2	Liver Diseases (Liver Disease) 01/2017 - 01/2017
2	Fibrosis (Cirrhosis) 01/2017 - 01/2017
2	Infections 12/2014 - 09/2003
1	Kidney Diseases (Kidney Disease) 01/2022
1	Intrahepatic Cholestasis of Pregnancy 01/2022
1	Tularemia 10/2020
1	Diverticulum 04/2018
1	Diverticulitis 04/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Carcinoma (Carcinomatosis) 04/2015
1	Spondylarthritis (Spinal Arthritis) 08/2014
1	Rheumatic Diseases (Rheumatism) 08/2014
1	Cicatrix (Scar) 02/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2012
1	Myocardial Infarction 02/2012
1	Cholelithiasis 01/2009
1	Virus Diseases (Viral Diseases) 03/2008
1	Body Weight (Weight, Body) 07/2007
1	Melanoma (Melanoma, Malignant) 07/2005

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 10/2020 - 02/2004
4	Gemcitabine FDA Link 04/2015 - 07/2005
4	Dextran SulfateIBA 09/2010 - 05/2003
3	Cancer VaccinesIBA 04/2015 - 04/2002
3	AntigensIBA 04/2015 - 07/2005
3	VaccinesIBA 04/2014 - 02/2011
2	AntibodiesIBA 10/2020 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2017
2	ISCOMsIBA 07/2011 - 02/2011
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2010 - 02/2004
2	Interleukin-18 (Interleukin 18)IBA 09/2010 - 02/2004
2	IceIBA 07/2007 - 02/2004
2	pralnacasanIBA 07/2007 - 02/2004
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2005 - 07/2005
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2018
1	ORALIT (ORS)IBA 01/2017
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 04/2015
1	Small Interfering RNA (siRNA)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 04/2015
1	OvalbuminIBA 04/2015
1	Tobramycin (Nebcin)FDA LinkGeneric 12/2014
1	Pharmaceutical PreparationsIBA 12/2014
1	Colistin (Coly-Mycin)FDA Link 12/2014
1	Fluconazole (Zonal)FDA LinkGeneric 12/2014
1	AutoantibodiesIBA 08/2014
1	ProgranulinsIBA 08/2014
1	Phosphates (Orthophosphate)IBA 02/2012
1	factor EF-PIBA 02/2012
1	Prostaglandins EIBA 08/2011
1	EpitopesIBA 02/2011
1	Combined VaccinesIBA 02/2011
1	Toll-Like Receptor AgonistsIBA 02/2011
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 09/2010
1	Dextrans (Dextran)FDA Link 09/2010
1	InflammasomesIBA 09/2010
1	Interferon Type IIBA 03/2008
1	GTP-Binding Proteins (G-Protein)IBA 03/2008
1	NucleotidesIBA 03/2008
1	Messenger RNA (mRNA)IBA 07/2007
1	ElementsIBA 07/2007
1	Caspase 1 (ICE Protease)IBA 07/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2005
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2005
1	Peptides (Polypeptides)IBA 07/2005
1	Fas Ligand Protein (Fas Ligand)IBA 07/2005
1	MART-1 AntigenIBA 07/2005
1	Antineoplastic Agents (Antineoplastics)IBA 07/2005
1	HLA-A*02:01 antigenIBA 07/2005
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 02/2004
1	Drinking WaterIBA 02/2004
1	InterleukinsIBA 02/2004
1	Interferon-alpha (Interferon Alfa)IBA 09/2003
1	mesopramIBA 05/2003
1	Phosphodiesterase InhibitorsIBA 05/2003
1	Interleukin-12 (IL 12)IBA 04/2002

Therapy/Procedure

4	Therapeutics 04/2015 - 01/2009
2	Oral Administration 09/2010 - 07/2007
1	Renal Dialysis (Hemodialysis) 01/2022
1	Drug Therapy (Chemotherapy) 04/2014
1	Ligation 02/2012
1	Immunotherapy 07/2005
1	Aftercare (After-Treatment) 07/2005